What one share of Acadia Pharmaceuticals holds
We are a biopharmaceutical company focused on turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world.
Acadia Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $6.61 |
|---|---|
| Profit | $2.21 |
| Capex (buildings and equipment) | $0.09 |
| Free cash flow | $0.85 |
| Cash and investments | $2.24 |
| Book value | $7.59 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | — | −$1.20 | — | — | — | $0.32 |
| 2010 | — | $0.39 | — | — | — | $0.75 |
| 2011 | — | −$0.44 | $0.00 | −$0.38 | — | $0.44 |
| 2012 | — | −$0.38 | — | — | — | $1.16 |
| 2013 | — | −$0.44 | $0.01 | −$0.38 | — | $2.00 |
| 2014 | — | −$0.95 | $0.00 | −$0.69 | — | $3.09 |
| 2015 | — | −$1.63 | $0.02 | −$1.23 | — | $1.96 |
| 2016 | $0.15 | −$2.34 | $0.01 | −$1.81 | — | $4.27 |
| 2017 | $1.02 | −$2.36 | $0.01 | −$1.78 | — | $2.69 |
| 2018 | $1.77 | −$1.94 | $0.02 | −$1.34 | — | $3.33 |
| 2019 | $2.30 | −$1.60 | $0.01 | −$1.03 | — | $4.50 |
| 2020 | $2.81 | −$1.79 | $0.05 | −$0.91 | — | $3.93 |
| 2021 | $3.02 | −$1.05 | $0.01 | −$0.79 | — | $3.36 |
| 2022 | $3.20 | −$1.34 | $0.00 | −$0.71 | — | $2.47 |
| 2023 | $4.43 | −$0.37 | $0.00 | $0.10 | — | $2.62 |
| 2024 | $5.76 | $1.36 | $0.00 | $0.94 | — | $4.40 |
| 2025 | $6.31 | $2.30 | $0.03 | $0.62 | — | $7.21 |
Common questions about Acadia Pharmaceuticals
How much does one share of Acadia Pharmaceuticals earn?
Over the last 12 months, each share of Acadia Pharmaceuticals earned $2.21 of profit on $6.61 of sales, keeping about 33¢ of every $1 (profit margin).
Does Acadia Pharmaceuticals pay a dividend?
Acadia Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Acadia Pharmaceuticals’s book value per share?
Acadia Pharmaceuticals’s book value is $7.59 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Acadia Pharmaceuticals have?
Each share of Acadia Pharmaceuticals has $2.24 of cash and investments, as of June 30, 2026.
What is Acadia Pharmaceuticals’s free cash flow per share?
$0.85 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Acadia Pharmaceuticals bought back shares?
Acadia Pharmaceuticals’s share count rose about 353% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.